Insulin Overdose Risk Results in Recall of 1.4M Smiths Medical Mislabeled Syringes
Smiths Medical is recalling about 1.4 million insulin syringes with skewed measurement markings which could result in an insulin overdose.
Smiths Medical is recalling about 1.4 million insulin syringes with skewed measurement markings which could result in an insulin overdose.
Another New York hospital has been found to have been reusing insulin pens on different patients, potentially exposing them to blood borne diseases like hepatitis C and HIV.
A Veterans Administration Center in Buffalo, New York hay have exposed more than 700 patients to a potential risk of bloodborne diseases by reusing insulin pens on multiple people.
The FDA and Nipro Medical Corporation have announced a nationwide recall of all GlucoPro Insulin Syringes due to a risk that the needle may break off of the syringe during…
The FDA issued a MedWatch safety alert on Tuesday to notify healthcare professionals and patients about a massive insulin syringe recall involving 250 million Accusure insulin syringes manufactured by Qualitest…
Two lots of Accusure insulin syringes have been recalled due to defective needles that can detach from the syringes during use, according to a notice posted by the FDA on…